These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15014289)

  • 21. Live attenuated influenza vaccine (FluMist®; Fluenz™): a review of its use in the prevention of seasonal influenza in children and adults.
    Carter NJ; Curran MP
    Drugs; 2011 Aug; 71(12):1591-622. PubMed ID: 21861544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized trial to compare the safety and immunogenicity of CSL Limited's 2009 trivalent inactivated influenza vaccine to an established vaccine in United States children.
    Brady RC; Hu W; Houchin VG; Eder FS; Jackson KC; Hartel GF; Sawlwin DC; Albano FR; Greenberg M
    Vaccine; 2014 Dec; 32(52):7141-7. PubMed ID: 25454878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A postmarketing evaluation of the frequency of use and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years.
    Tennis P; Toback SL; Andrews E; McQuay LJ; Ambrose CS
    Vaccine; 2011 Jul; 29(31):4947-52. PubMed ID: 21596087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimizing protection against influenza in children eligible for the vaccine for children program.
    Hull HF; O'Connor H
    Pediatr Infect Dis J; 2010 Oct; 29(10):910-4. PubMed ID: 20431426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging data on the safety and efficacy of influenza vaccines in children.
    Vesikari T
    Pediatr Infect Dis J; 2008 Nov; 27(11 Suppl):S159-61. PubMed ID: 18955892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.
    Piedra PA; Gaglani MJ; Riggs M; Herschler G; Fewlass C; Watts M; Kozinetz C; Hessel C; Glezen WP
    Pediatrics; 2005 Sep; 116(3):e397-407. PubMed ID: 16140685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Live attenuated or inactivated influenza vaccines and medical encounters for respiratory illnesses among US military personnel.
    Wang Z; Tobler S; Roayaei J; Eick A
    JAMA; 2009 Mar; 301(9):945-53. PubMed ID: 19255113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of inactivated influenza vaccine in children.
    Wright PF
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):200-5. PubMed ID: 17055371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inactivated influenza virus vaccines: the future of TIV and QIV.
    Schotsaert M; García-Sastre A
    Curr Opin Virol; 2017 Apr; 23():102-106. PubMed ID: 28505524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age.
    Halasa NB; Gerber MA; Berry AA; Anderson EL; Winokur P; Keyserling H; Eckard AR; Hill H; Wolff MC; McNeal MM; Edwards KM; Bernstein DI
    J Pediatric Infect Dis Soc; 2015 Sep; 4(3):214-24. PubMed ID: 26334249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccination of children with a live-attenuated, intranasal influenza vaccine - analysis and evaluation through a Health Technology Assessment.
    Andersohn F; Bornemann R; Damm O; Frank M; Mittendorf T; Theidel U
    GMS Health Technol Assess; 2014; 10():Doc03. PubMed ID: 25371764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of live attenuated influenza vaccine in children 6 months to 17 years of age.
    Belshe RB; Toback SL; Yi T; Ambrose CS
    Influenza Other Respir Viruses; 2010 May; 4(3):141-5. PubMed ID: 20409210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influenza vaccination type, live, attenuated influenza vaccine (LAIV) versus inactivated influenza vaccine (IIV), received by children, United States, 2011-12 through 2013-14 influenza seasons.
    Kahn KE; Santibanez TA; Zhai Y; Singleton JA
    Vaccine; 2015 Sep; 33(39):5196-203. PubMed ID: 26238724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Live attenuated influenza vaccine in children.
    Ambrose CS; Walker RE; Connor EM
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):206-12. PubMed ID: 17055372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A postlicensure evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 24-59 months of age.
    Toback SL; Ambrose CS; Eaton A; Hansen J; Aukes L; Lewis N; Wu X; Baxter R
    Vaccine; 2013 Apr; 31(14):1812-8. PubMed ID: 23395734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines.
    Sasaki S; Jaimes MC; Holmes TH; Dekker CL; Mahmood K; Kemble GW; Arvin AM; Greenberg HB
    J Virol; 2007 Jan; 81(1):215-28. PubMed ID: 17050593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children.
    King JC; Fast PE; Zangwill KM; Weinberg GA; Wolff M; Yan L; Newman F; Belshe RB; Kovacs A; Deville JG; Jelonek M;
    Pediatr Infect Dis J; 2001 Dec; 20(12):1124-31. PubMed ID: 11740317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A whole genome transcriptional analysis of the early immune response induced by live attenuated and inactivated influenza vaccines in young children.
    Zhu W; Higgs BW; Morehouse C; Streicher K; Ambrose CS; Woo J; Kemble GW; Jallal B; Yao Y
    Vaccine; 2010 Apr; 28(16):2865-76. PubMed ID: 20153794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age.
    Belshe RB; Ambrose CS; Yi T
    Vaccine; 2008 Sep; 26 Suppl 4():D10-6. PubMed ID: 18611422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.